I know this is an issue that doesn't necessarily fit natural to Congress to be funding physician and provider education, but we're talking about next year reports suggesting that 8 of the top 10 drugs on the market are going to be biosimilars.
On the recordSeptember 16, 2015
Source
congress.govEditor's note · Context
Senator Murphy discusses the need for funding education on biosimilars amidst rising drug costs.
Share
More from Chris Murphy
Aug 5, 2026
Tinnitus is the most common service-connected disability recognized by VA, with an estimated 3.6 million veterans receiving benefits for this condition.
Aug 10, 2026
The supposed deal that’s on the table right now would pay Iran $100 million, excuse me, $100 billion a year, in order to reopen the Strait.
Aug 8, 2026
Weighing that against the boost for Ukraine, I think it’s important to support Ukraine right now.
Aug 11, 2026
I was glad that the president got a ceasefire [in June], but I could tell by the terms it wasn't going to last. It wasn't a real agreement, but at this point, many of us are willing to support almost any agreement.





